LINC01947

Across TCGA pan-cancer cohorts, LINC01947 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC01947 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01947 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01947 expression acts as an unfavorable survival marker.

CHOL, LIHC, and MESO are the cancer types where LINC01947 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.675	<.001	81	view →
LIHC	OS	Tertile	II,III,IV	0.406	0.724	<.001	72	view →
MESO	OS	Tertile	II,III,IV	0.313	0.587	.014	54	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	36	view →
UVM	OS	Tertile	All	0.302	0.710	.015	12	view →
KIRP	DFS	Tertile	All	0.678	0.873	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC01947–CHOL (OS)

Open the CHOL breakdown →